Design Cloud

Image Name

News

Home page

Party group dynamics

Employee activity

Wanbangde Pharmaceutical Group Co., Ltd. Announces Environmental Measures for New Technical Upgrade Project: Annual Production Capacity of 5 tons of Resorcinol API and 500 tons of Cimetidine API

Date:

11 Jun,2022

The company plans to build a technical upgrade project aimed at producing 5 tons of resorcinol API and 500 tons of cimetidine API annually. The construction details of this project are now being publicly announced.

Previous page

Adhering to the Work Safety Law and Taking on Primary Responsibility | Wanbangde Pharmaceutical Group Holds 2022 "Work Safety Month" Kickoff Meeting

Spring Outing Diary | Wanbangde Pharmaceutical Group’s National Fitness Event Successfully Concludes

Next page

Related Recommendations

Image Name

2025/04/14

Mingjie Pharma's inaugural national CMC pharmacy salon tour for 2025 concludes successfully | Wanbangde Pharmaceutical deeply engages in technical exchanges

Image Name

2025/04/14

Good News | Maband Pharmaceutical Group's Mecobalamin Granted Orphan Drug Designation by the U.S. FDA for the Treatment of ALS

Image Name

2025/04/14

[Another Milestone: Wanbangde Pharmaceutical Group's Huperzine A Injection Included in the "Clinical Guidelines for Rational Drug Use in Cerebrovascular Diseases"]

< 1 2 3 4...78 > proceed page

Image Name

Website Development: China Enterprise Dynamics Taizhou

Business license

浙ICP备10002622号-38